Home › Funds › Ethic Inc. › ABT

Ethic Inc. position in ABT

ABBOTT LABORATORIES · Health Care

Ethic Inc. reported holding 267,333 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$26.4M, representing 0.30% of its reported portfolio and ranking #46 among its reported holdings. Ethic Inc. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)267.33K sh
Reported value held$26.42M
Portfolio Weight0.30%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Ethic Inc.'s ABT position evolved

Ethic Inc. first disclosed a stake in ABT in Q3 2023 at 136,594 shares (US$13.2M). The position peaked in Q2 2025 at 233,182 shares, worth US$31.3M. Across 13 filings, Ethic Inc. increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 267,333 shares valued at US$26.4M — an increase of 10,876 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 136.59K $13.23M New
Q4 2023 150.66K $16.58M Add
Q1 2024 167.40K $19.03M Add
Q2 2024 171.50K $17.82M Add
Q3 2024 167.40K $19.03M Reduce
Q4 2024 188.28K $21.30M Add
Q1 2025 218.42K $28.76M Add
Q2 2025 233.18K $31.33M Add
Q3 2025 223.66K $29.96M Reduce
Q4 2025 219.20K $27.46M Reduce
Q1 2026 224.62K $23.06M Add
Q2 2026 256.46K $23.27M Add
Q3 2026 267.33K $26.42M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Ethic Inc. held ABT?

Ethic Inc. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Ethic Inc.'s current position in ABT?

As of Q3 2026, Ethic Inc. holds 267.33K shares of ABT (ABBOTT LABORATORIES), valued at $26.42M, representing 0.30% of its reported portfolio and ranking #46.

Has Ethic Inc. been buying or selling ABT?

In the latest 13F filing (Q3 2026), Ethic Inc. increased its position in ABT. The position peaked in Q2 2025 at 233.18K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.